China as an Emerging Center of Innovation

3:00 PM - 4:00 PM (EST), Tuesday, February 16, 2021
Recent deal announcements are giving evidence to Chinese companies being at the heels of their western counterparts in terms of developing innovative treatments. With transaction deals doubling 2019 to the tune of $3.1B USD (from Jan-June 2020), all eyes are on China. What is driving this revolution in Chinese biotech? How has the wider community responded? Join experts from pharma, biotech and venture as they discuss what factors are contributing to this radical transformation.
Moderator
photo
Executive Vice President, International Affairs
BIO
Speakers
photo
Head JLABS @ Shanghai
Johnson & Johnson
photo
Chairman and CEO
D3 Bio
photo
Executive Vice President, International Affairs
BIO
photo
Co-Founder, CEO and Chairman of the Board
Beigene
photo
Chief Executive Officer
Apollomics, Inc.
photo
Founding Partner
Lyfe Capital